Change Healthcare is primarily known for its state-of-the-art technology and business solutions, but the company also provides consulting services, including overall assessments of an organization’s overall business health. Sometimes, healthcare providers know they need help keeping up with the rest of the industry, but need to be pointed in the right direction before they can get started; that’s where Change Healthcare enters the equation.

Radiation therapy can lower the chance of cancer recurrence in patients with low-risk breast cancer following breast conservation surgery, according to data presented Oct. 21 at the American Society for Radiation Oncology (ASTRO) Annual Meeting in San Antonio, Texas.

Strains of C. diff—a bacteria that can cause inflammation of the colon—can survive commercial laundry practices in hospitals, according to a recent study published in Infection Control & Hospital Epidemiology.

Primary care physicians who order a large number of one low-value screening test tend to order large numbers of other low-value screening tests as well, according to a new study published in JAMA Network Open. The authors suggested that high-intensity interventions focused on these physicians may be one way to reduce such low-value care going forward.

Researchers have found that high-dose radiation therapy can improve survival for oligometastatic patients, according to findings to be presented at the 2018 Annual Meeting of the American Society for Radiation Oncology (ASTRO).

The Department of Justice indicted four men and seven companies for their roles in a $1 billion healthcare fraud scheme and announced plea deals and another charge.

Two major healthcare insurers, Aetna and Humana, are set to dole out hundreds of thousands of dollars to settle separate disputes over health information disclosures and inadequate network coverage.

New research out of Sweden found that digital breast tomosynthesis (DBT), or 3D mammography, can detect 34 percent more breast cancers than traditional mammography. A majority of the identified breast tumors were classified as invasive.